These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 37190141)

  • 1. Inflammatory Networks in Renal Cell Carcinoma.
    Kruk L; Mamtimin M; Braun A; Anders HJ; Andrassy J; Gudermann T; Mammadova-Bach E
    Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of apoptosis repressor with a CARD domain (ARC) in the therapeutic resistance of renal cell carcinoma (RCC): the crucial role of ARC in the inhibition of extrinsic and intrinsic apoptotic signalling.
    Toth C; Funke S; Nitsche V; Liverts A; Zlachevska V; Gasis M; Wiek C; Hanenberg H; Mahotka C; Schirmacher P; Heikaus S
    Cell Commun Signal; 2017 May; 15(1):16. PubMed ID: 28464919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crosstalk of Inflammatory Cytokines within the Breast Tumor Microenvironment.
    Habanjar O; Bingula R; Decombat C; Diab-Assaf M; Caldefie-Chezet F; Delort L
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of inflammation in kidney cancer.
    de Vivar Chevez AR; Finke J; Bukowski R
    Adv Exp Med Biol; 2014; 816():197-234. PubMed ID: 24818725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unraveling the molecular mechanisms between inflammation and tumor angiogenesis.
    Zhou W; Yang L; Nie L; Lin H
    Am J Cancer Res; 2021; 11(2):301-317. PubMed ID: 33575073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquired resistance to cancer immunotherapy: Role of tumor-mediated immunosuppression.
    Saleh R; Elkord E
    Semin Cancer Biol; 2020 Oct; 65():13-27. PubMed ID: 31362073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calbindin S100A16 Promotes Renal Cell Carcinoma Progression and Angiogenesis via the VEGF/VEGFR2 Signaling Pathway.
    Wang N; Wang R; Tang J; Gao J; Fang Z; Zhang M; Shen X; Lu L; Chen Y
    Contrast Media Mol Imaging; 2022; 2022():5602011. PubMed ID: 36176934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation and Myeloid Cells in Cancer Progression and Metastasis.
    Deng J; Fleming JB
    Front Cell Dev Biol; 2021; 9():759691. PubMed ID: 35127700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammation and cancer.
    Singh N; Baby D; Rajguru JP; Patil PB; Thakkannavar SS; Pujari VB
    Ann Afr Med; 2019; 18(3):121-126. PubMed ID: 31417011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic inflammation in cancer development.
    Multhoff G; Molls M; Radons J
    Front Immunol; 2011; 2():98. PubMed ID: 22566887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Underlying Causes and Therapeutic Targeting of the Inflammatory Tumor Microenvironment.
    Comen EA; Bowman RL; Kleppe M
    Front Cell Dev Biol; 2018; 6():56. PubMed ID: 29946544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total glucosides of paeony inhibit breast cancer growth by inhibiting TAMs infiltration through NF-κB/CCL2 signaling.
    Jin L; Guo Y; Mao W; Wang J; Jin L; Liu X; Shou Q; Fu H
    Phytomedicine; 2022 Sep; 104():154307. PubMed ID: 35841664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond Cell Motility: The Expanding Roles of Chemokines and Their Receptors in Malignancy.
    Morein D; Erlichman N; Ben-Baruch A
    Front Immunol; 2020; 11():952. PubMed ID: 32582148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological Approaches Towards Cancer and Inflammation: A Cross Talk.
    Qu X; Tang Y; Hua S
    Front Immunol; 2018; 9():563. PubMed ID: 29662489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic Regulation of Inflammatory Cytokine-Induced Epithelial-To-Mesenchymal Cell Transition and Cancer Stem Cell Generation.
    Markopoulos GS; Roupakia E; Marcu KB; Kolettas E
    Cells; 2019 Sep; 8(10):. PubMed ID: 31557902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Inflammation in Cancer Prevention and Therapy.
    Todoric J; Antonucci L; Karin M
    Cancer Prev Res (Phila); 2016 Dec; 9(12):895-905. PubMed ID: 27913448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autocrine MCP-1/CCR2 signaling stimulates proliferation and migration of renal carcinoma cells.
    Küper C; Beck FX; Neuhofer W
    Oncol Lett; 2016 Sep; 12(3):2201-2209. PubMed ID: 27602164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A chemokine network of T cell exhaustion and metabolic reprogramming in renal cell carcinoma.
    Pichler R; Siska PJ; Tymoszuk P; Martowicz A; Untergasser G; Mayr R; Weber F; Seeber A; Kocher F; Barth DA; Pichler M; Thurnher M
    Front Immunol; 2023; 14():1095195. PubMed ID: 37006314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of immune cells and cytokines on inflammation and immunosuppression in the tumor microenvironment.
    Li L; Yu R; Cai T; Chen Z; Lan M; Zou T; Wang B; Wang Q; Zhao Y; Cai Y
    Int Immunopharmacol; 2020 Nov; 88():106939. PubMed ID: 33182039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine- and chemokine-induced inflammatory colorectal tumor microenvironment: Emerging avenue for targeted therapy.
    Bhat AA; Nisar S; Singh M; Ashraf B; Masoodi T; Prasad CP; Sharma A; Maacha S; Karedath T; Hashem S; Yasin SB; Bagga P; Reddy R; Frennaux MP; Uddin S; Dhawan P; Haris M; Macha MA
    Cancer Commun (Lond); 2022 Aug; 42(8):689-715. PubMed ID: 35791509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.